Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant cell line stably expressing swine fever virus e2 protein and its application in the preparation of swine fever subunit vaccine and diagnostic reagent

A technology for stable expression of swine fever virus, applied in antiviral agents, cells modified by introducing foreign genetic material, application, etc., can solve problems such as increased difficulty in production process, poor folding and modification, cell lysis, etc., to achieve antibody persistence Long time, easy to cultivate, and rapid growth effect

Active Publication Date: 2016-05-18
HARBIN WEIKE BIOTECH DEV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still some differences with the natural antigenic protein structure of the virus, and the folding and modification of the protein after expression is not as good as that of the mammalian cell expression system
Moreover, when the system produces and prepares antigens, the cells will lyse and die after being infected by the virus, which will increase the difficulty of downstream purification and other production processes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant cell line stably expressing swine fever virus e2 protein and its application in the preparation of swine fever subunit vaccine and diagnostic reagent
  • Recombinant cell line stably expressing swine fever virus e2 protein and its application in the preparation of swine fever subunit vaccine and diagnostic reagent
  • Recombinant cell line stably expressing swine fever virus e2 protein and its application in the preparation of swine fever subunit vaccine and diagnostic reagent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1 Construction and detection of a recombinant cell line stably expressing classical swine fever virus E2 protein

[0044] 1 Materials and methods

[0045] 1.1 Plasmids, strains and cells

[0046] The eukaryotic expression vector plasmid pCAG-neo, DH5α competent cells and BHK-21 cells are preserved by the State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences. The plasmid extraction kit and RNA extraction kit are products of QIAGEN, DNA Gel recovery kit was purchased from Shanghai Huashun Biotechnology Co., Ltd., G418 was purchased from Gibco, trypsin was purchased from Hyclone, ReverseTranscriptaseM-MLV﹑PrimeSTAR TM HSDNA Polymerase﹑SalI﹑XhoI﹑BamHI﹑T4DNA ligase was purchased from TaKaRa Company, the anti-CSFVE2 protein monoclonal antibody was prepared by our research group, the classical swine fever virus antigen ELISA detection kit was the product of MedianDiagnostics, and the classical ...

Embodiment 2

[0072] Example 2 Cell line expressing recombinant protein to the immune protection test of pig

[0073]Vaccine preparation: When the recombinant mammalian cell line BCSFV-E2 cells (CGMCC No.7719) constructed and screened in Example 1 grow to 90% full after normal passage, change the low serum medium (serum content is 1-2%) and continue Cultivate for 4-6 days, harvest the cell culture supernatant and store it at 4°C. The cell supernatant is concentrated by ultrafiltration with a molecular weight cut-off of 50kD until the ELISA titer of E2 antigen is 1:160 to 1:320, and the final concentration is 0.02% thimerosal. After that is the vaccine antigen solution. The vaccine antigen solution and MONTANIDEISA206VG adjuvant were mixed and fully emulsified at a weight ratio of 1:1 to prepare a water-in-oil-in-water vaccine. The attenuated vaccine in the control group was a commercially available swine fever cell vaccine (derived from primary bovine testicular cells).

[0074] Animal gr...

Embodiment 3

[0084] Embodiment 3 uses recombinant cell line to express antigen indirect ELISA method to detect swine fever virus antibody

[0085] The BCSFV-E2 cells were expanded and cultured, and the cell culture supernatant was harvested. The cell supernatant was centrifuged at low speed to remove impurities such as cell debris, and then filtered through a 0.45 μm filter membrane for clarification. The clarified supernatant was then concentrated by ultrafiltration with a molecular weight cut-off of 50kD. After being concentrated by about 40 times of volume, it is centrifuged at 12000rpm to remove insoluble impurities. After concentration, the supernatant was dialyzed with pH 8.0 Tris-HCl buffer, combined with DEAE anion resin chromatography column, washed and eluted with pH 8.0 Tris-HCl, 250mM NaCl buffer itd, and the active peak was collected protein. After being concentrated by ultrafiltration, it was chromatographed by molecular sieve chromatography to collect the active peak prot...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a strain of a recombinant cell line for stably expressing classical swine fever virus E2 protein, and applications of the recombinant cell line in preparation of subunit vaccines and diagnosis reagents of classical swine fever, wherein specifically the recombinant cell line is BCSFV-E2, is preserved in the China General Microbiological Culture Collection Center, and has the preservation number of CGMCC No.7719. The classical swine fever subunit vaccine prepared by using the recombinant cell line has characteristics of high safety, good immunization effect, easy mass production, less being susceptible to exogenous virus pollution or influence of antibodies, and no influence of the maternal antibody on immunization of swine, and can induce and produce high level classical swine fever virus neutralization antibodies after the swine is immunized. In addition, the present invention further discloses a method for constructing the recombinant mammalian cell line, a method for preparing the classical swine fever subunit vaccine, and applications of the antigen expressed by the recombinant cell line in preparation of classical swine fever prevention vaccines and diagnosis reagents.

Description

technical field [0001] The present invention relates to a recombinant mammalian cell line stably expressing classical swine fever virus E2 protein and its application in the preparation of classical swine fever subunit vaccines and diagnostic reagents. Specifically, the recombinant cell line involved in the present invention is BCSFV-E2, which The deposit number is: CGMCCNo.7719. The invention also discloses a method for preparing the recombinant cell line and the application of the recombinant cell line in preparing a vaccine for preventing swine fever and in preparing reagents for diagnosing or detecting swine fever virus infection. The invention belongs to the technical field of animal vaccines and veterinary biological products. Background technique [0002] Classical swine fever (CSF), also known as hog cholera (Hogcholera, HC), is an acute febrile fatal disease caused by swine fever virus (HogCholeravirus, HCV or Classical swinefevervirus, CSFV). Widespread, high mor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/187A61K9/107A61P31/14G01N33/68G01N33/569C12N15/85C12N15/40C12N5/10C12R1/91
Inventor 华荣虹步志高
Owner HARBIN WEIKE BIOTECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com